Concord Drugs Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Concord Drugs Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
36.02% Fall from 52W High
-2.7
TTM PE Ratio
Below industry Median
43.5
Price to Book Ratio
Low in industry
1.2
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-48.9
RSI
RSI is mid-range
64.2
MFI
MFI is mid-range
62.6

Concord Drugs Ltd shareholding Pattern

Promoter
55.4%
Public
44.6%
Promoter
55.4%
Public
44.6%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
52.1%
Public
47.9%
Promoter
49%
Public
51%

Concord Drugs Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
15
Bearish Moving Averages
1
5Day EMA
38.00
10Day EMA
37.40
12Day EMA
37.30
20Day EMA
37.10
26Day EMA
37.10
50Day EMA
37.70
100Day EMA
38.30
200Day EMA
37.40
5Day SMA
37.60
10Day SMA
36.80
20Day SMA
36.90
30Day SMA
37.10
50Day SMA
37.00
100Day SMA
40.90
150Day SMA
39.20
200Day SMA
38.20
Delivery & Volume
Resistance & Support
39.17
Pivot
Resistance
First Resistance
40.13
Second Resistance
40.92
Third Resistance
41.88
Support
First Support
38.38
Second support
37.42
Third Support
36.63
Relative Strength Index
64.19
Money Flow Index
62.56
MACD
0.17
MACD Signal
-0.17
Average True Range
2.19
Average Directional Index
17.72
Rate of Change (21)
7.66
Rate of Change (125)
19.24
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Veerhealth Care Ltd.
-
-
-
Gujarat Terce Laboratories Ltd.
-
-
-
Vivanza Biosciences Ltd.
-
-
-
Concord Drugs Ltd.
-
-
-
Murae Organisor Ltd.
-
-
-
Vilin Bio Med Ltd.
-
-
-
Sunrest Lifescience Ltd.
-
-
-

Concord Drugs Ltd Company background

Founded in: 1995
Managing director: S Nagi Reddy
Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue BioAdhesive, tablets, capsules and ophthalmic preparations and Readytofill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved. The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad. State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Readytofill Pellets ensures the highest level of process integrity and product quality.The Company started with Finished Pharmaceutical Formulations and then diversified into Readytofill Pellets, to provide customers with endtoend solution to their various pharmaceutical product needs to commercial contract drug manufacturing. It is engaged in developing New products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. It operates a state of the art, cGMP contract manufacturing FormulationFillFinish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
Read More

Concord Drugs Ltd FAQs

You can easily buy Concord Drugs Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage